Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.

ABSTRACT: Colorectal cancer (CRC) accounts for ~9% of all cancers in the Veteran population, a fact which has focused a great deal of the attention of the VA's research and development efforts. A field-based meeting of CRC experts was convened to discuss both challenges and opportunities in precision medicine for CRC. This group, designated as the VA Colorectal Cancer Cell-genomics Consortium (VA4C), discussed advances in CRC biology, biomarkers, and imaging for early detection and prevention. There was also a discussion of precision treatment involving fluorescence-guided surgery, targeted chemotherapies and immunotherapies, and personalized cancer treatment approaches. The overarching goal was to identify modalities that might ultimately lead to personalized cancer diagnosis and treatment. This re

SUBMITTER: Mohapatra SS 

PROVIDER: S-EPMC5895694 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature